16 min read
Keypoint Newsletter: May 2025
Featuring...
Dr. Livia Yamashiro is a Scientist at Arcus Biosciences where she applies fundamental immunology to the development of drugs for cancer immunotherapies. Her focus is to phenotype immune responses and validate the application of promising candidates in clinical trials. She also investigates compounds with cancer cell-intrinsic activity, aiming to find molecules with selective activity towards tumoral cells avoiding unspecific effects. Livia has a background in immunology related to host innate immune system-pathogen interactions having studied the Stimulator of Interferon Genes (STING) pathway and the downstream effects on infectious diseases during her postdoctoral fellowship at UC Berkeley. Additionally, Livia has been involved in the screening of compounds with antiviral activity against SARS-CoV-2 and successfully established animal models to investigate top hit candidates.
Research Area(s):
ImmunologyResearch Keywords:
Mentor: Deepak Sampath, PhD
May 6, 2025 by Shannon Weiman
Featuring...
Apr 23, 2025 by Shannon Weiman
Our April Fellow's Spotlight goes to Dr. Vivien Maltez, PhD, an Assistant Professor in the Division of Allergy,...